Protein L is a multidomain cell wall bound protein found in ϳ10% of the Peptostreptococcal isolates (1) and contains a series of repeated domains, some of which are able to bind to immunoglobulins without initiating an immune response. Expression of this protein has been correlated to the virulence of these opportunistic pathogenic bacteria (1) that are found in the gastrointestinal and urogenital tracts (2). Its presence has been found to cause cellular responses such as histamine release from basophils and mast cells (3) is a rigid structure consisting of a ␤-sheet, formed by two pairs of antiparallel ␤-strands, lying on top of a single ␣-helical section (4), with a flexible N terminus (5). Further NMR studies (6) led to the proposal that the binding site of PpL 312 for -chain involves residues from the second ␤-strand and from the loop between the third ␤-strand and the ␣-helix and located the binding site for PpL 312 on the -chain to the second ␤-strand and the two ␤-strands located on the outer surface of the framework region of the V L domain (7). Parallel studies on the binding interaction of a single Igbinding domain of protein L from strain 3316 (PpL 3316 ) found that it forms a high affinity complex with -chains with a K d of 112 nM (8, 9). The x-ray crystallographic structure of this domain has been determined in complex with the human antibody fragment, Fab 2A2, and revealed that two Fab 2A2 fragments can in fact bind to sites on opposite faces of PpL 3316 (10). Site 1 of PpL 3316 is that characterized by Beckingham et al. (9) and equivalent to the site studied on PpL 312 using NMR by Wikström et al. (5). Site 2 of PpL 3316 , involving part of the helix and strands 3 and 4, was identified for the first time by the crystallographic study (10). This site has not yet been characterized although preliminary studies suggested that the affinity of site 2 is lower than that of site 1 (10).
Protein L is a multidomain cell wall bound protein found in ϳ10% of the Peptostreptococcal isolates (1) and contains a series of repeated domains, some of which are able to bind to immunoglobulins without initiating an immune response. Expression of this protein has been correlated to the virulence of these opportunistic pathogenic bacteria (1) that are found in the gastrointestinal and urogenital tracts (2) . Its presence has been found to cause cellular responses such as histamine release from basophils and mast cells (3) presumably by crosslinking IgE molecules bound to surface Ig receptors. 1 H NMR spectroscopy of a single Ig-binding domain of protein L (isolated from strain 312, PpL 312 ) 1 revealed that PpL 312 is a rigid structure consisting of a ␤-sheet, formed by two pairs of antiparallel ␤-strands, lying on top of a single ␣-helical section (4), with a flexible N terminus (5) . Further NMR studies (6) led to the proposal that the binding site of PpL 312 for -chain involves residues from the second ␤-strand and from the loop between the third ␤-strand and the ␣-helix and located the binding site for PpL 312 on the -chain to the second ␤-strand and the two ␤-strands located on the outer surface of the framework region of the V L domain (7) . Parallel studies on the binding interaction of a single Igbinding domain of protein L from strain 3316 (PpL 3316 ) found that it forms a high affinity complex with -chains with a K d of 112 nM (8, 9) . The x-ray crystallographic structure of this domain has been determined in complex with the human antibody fragment, Fab 2A2, and revealed that two Fab 2A2 fragments can in fact bind to sites on opposite faces of PpL 3316 (10) . Site 1 of PpL 3316 is that characterized by Beckingham et al. (9) and equivalent to the site studied on PpL 312 using NMR by Wikström et al. (5) . Site 2 of PpL 3316 , involving part of the helix and strands 3 and 4, was identified for the first time by the crystallographic study (10) . This site has not yet been characterized although preliminary studies suggested that the affinity of site 2 is lower than that of site 1 (10) .
By use of a program of site directed mutagenesis we have been able to derive the relative binding affinities of sites 1 and 2 and propose a mechanism by which PpL 3316 binds light chains that is consistent with published data. The hydroxyl group of Tyr 53 is important for the formation of a high affinity complex at site 1. Previous enzyme-linked immunosorbent assay experiments (11) have shown that nitration of Tyr 53 or its mutation to Phe dramatically increases the K d of the -chainPpL 3316 interaction. Another important residue at site 1 is Leu 57 . No binding of the 1 -chain used in these studies can be detected at site 1 of the mutant Y53F/L57H by fluorimetry or isothermal titration calorimetry, and this mutant is thus ideal for measuring the affinity at site 2.
Important residues for binding at site 2 are Asp 55 and Ala 66 . The mutation D55A eliminates a salt bridge and dramatically weakens or eliminates binding (12) , and conversely, the mutation A66W is predicted to cause a steric clash removing binding at site 2. This is born out by fluorimetry experiments reported here and therefore the A66W PpL 3316 is suitable for determining the affinity of site 1.
The fluorescence properties of tryptophan residues are highly sensitive to their immediate environment (13) , and changes in the fluorescence emission from Trp residues have been used to study protein folding and unfolding events, pro-tein conformational changes, and to monitor binding interactions between proteins and various ligands (14) . We have therefore introduced unique Trp residues into PpL 3316 to monitor the binding reaction with -chain. Previous fluorescence studies have used F39W PpL 3316 to report the binding interaction between -chain and PpL 3316 . However, upon introduction of secondary mutations into the F39W PpL 3316 construct, expression levels and stability of the protein are compromised. Therefore the I34W PpL 3316 mutant, which has a Trp residue located toward the N terminus of ␤-strand 2, has been selected to study binding at the site 1 interface (see Fig. 1a) ; this construct is tolerant to the introduction of further mutations. The mutant Y64W PpL 3316 (Trp residue on ␤-strand 3 and close to residues Thr 65 , Ala 66 , Asp 67 , and Leu 68 , all of which are involved in site 2 contacts (10)) was made to monitor binding at site 2 (see Fig. 1b ).
EXPERIMENTAL PROCEDURES
Phosphate buffers and other reagents were all of analytical grade and purchased from BDH. The human IgG and 1 -chain for fluorescence experiments were generous gifts from Professor Martin Glennie, Southampton General Hospital, UK.
Mutagenesis-The mutated PpL 3316 constructs, I34W, Y64W, and Y64W/Y53F, were produced through the Kunkel method (15) of sitedirected mutagenesis. The I34W/Y53F, I34W/Y53F/L57H, Y64W/Y53F/ L57H, A66W, and I34W/A66W PpL 3316 mutant proteins were made through two-sided splicing by overlap extension PCR mutagenesis (16) . The presence of each mutation was confirmed by DNA sequencing and the mutant proteins were prepared in the same manner as the wildtype (wt) protein (8) .
Fluorescence Measurements-Fluorescence emission spectral measurements were made on a Hitachi F-2000 fluorimeter, with the temperature of the cell being maintained at 15°C by circulating water. All solutions were prepared in filtered 20 mM potassium phosphate buffer, pH 8.0. Scans of the emission spectra were made using excitation and emission band passes of 5 nm. Emission spectra were measured using excitation wavelengths of 280 and 295 nm, with a scan rate of 60 nm/min.
Stopped-flow Fluorescence Measurements-An Applied Photophysics SX.17MV stopped-flow spectrophotometer fitted with a 2-ml syringe was used to study pre-equilibrium fluorescence changes upon mixing of PpL 3316 with -chain. The temperature was maintained at 15°C (unless otherwise stated) using a Neslab RTE-111 circulating water bath. Measurements were made over various time courses between 0.2 and 200s, collecting 1000 data points with oversampling activated. Excitation wavelengths of 280 or 295 nm were selected by a monochromator and fluorescence emission above 335 nm was selected using a cut-off filter. All solutions were prepared in filtered and degassed 20 mM potassium phosphate buffer, pH 8.0. Each reaction was carried out in triplicate and the data averaged and analyzed using the manufacturer's software and single or double exponential curve fitting algorithms.
For the determination of the rate constants for the association and dissociation of the complex, the concentration of -chain was kept at 1.5 M, and the concentrations of the PpL 3316 mutants were varied between 10 and 50 M. Alternatively, in some experiments the concentration of PpL 3316 was kept constant at 1.5 M, and the concentration of -chain was varied.
To study the rate of dissociation of the complexes formed between PpL 3316 mutants and -chain, a solution containing a preformed complex (3 M -chain and 3 M mutant PpL 3316 ) was rapidly diluted by an equal volume of the non-fluorescent (above 335 nm) wt PpL 3316 (30 M). Isothermal Titration Calorimetry-Isothermal titration calorimetry was carried out using a Microcal VP-ITC at 15°C, with protein solutions prepared in 20 mM potassium phosphate buffer, pH 8.0. The interaction of wt PpL 3316 with -chain was studied through the titration of aliquots of 360 M -chain into 15 M wt PpL 3316 . Heat changes associated with the dilution of the -chain were measured by the titration of aliquots of 360 M -chain into 20 mM potassium phosphate buffer, pH 8.0. The enthalpy profile for the control titration into buffer was subtracted from the experimental data, with the resulting binding data being analyzed using the manufacturer's software.
To further resolve the binding interactions of -chain at sites 1 and 2 of PpL 3316 , mutant PpL 3316 constructs with site 2 or site 1 eliminated (737 and 650 M, respectively) were titrated into -chain (28.3 and 25 M, respectively). As above, binding data from these titrations were analyzed using the manufacturer's software.
Circular Dichroism-CD measurements were made using a Jasco J-720 CD spectrometer thermostated at 15°C. The spectra between 195 and 250 nm were measured at a scan rate of 50 nm/min using a 1-mm path length. The spectra were scanned in triplicate, with a response time of 4 s, slitwidth of 500 m, bandwidth of 1.0 nm, and resolution of 0.2 nm. Spectral corrections and calculations were carried out using the manufacturer's software, and the units are given in mean residue ellipticity.
RESULTS AND DISCUSSION
Changes in the environment of the Trp reporter groups were examined by comparing the emission spectra of 1.5 M -chain and 1.5 M of each of the PpL 3316 mutants, in free solution and complex, using excitation wavelengths of 280 and 295 nm. The spectra showed that Trp 64 and Trp 34 have wavelengths of maximum emission at 335 and 345 nm, respectively, indicating that Trp 64 is in a more hydrophobic environment than Trp 34 . The latter points downwards from ␤-strand 2 into the solvent and away from the center of the domain, whereas the side chain of Trp 64 is surrounded by side chains from the ␣-helix and ␤-strand 2 (see Fig. 1 ). No detectable shift in position of maximum emission is noted for the Y64W PpL 3316 ⅐-chain complex; however, a 5-nm blue shift is seen with the I34W PpL 3316 ⅐-chain complex suggesting that Trp 34 becomes less solvent exposed on complex formation. Details of the spectral characteristics of the various PpL 3316 ⅐-chain complexes, and the same proteins in free solution are given in Tables I and II . The data show that both the I34W and Y64W PpL 3316 domains exhibit fluorescence intensity changes upon complex formation with -chain. The intensity of Trp 34 decreases significantly whether excited at 280 or 295 nm, whereas that of Trp 64 increases slightly when excited at 295 nm but decreases when excited at 280 nm.
The respective distances of these residues from Tyr 53 are ϳ10 Å and 15 Å, respectively, well within the critical distance It should be noted that no fluorescence intensity changes (excited by light at 295 nm) occur when -chain is mixed with the I34W/Y53F/L57H or Y64W/A66W PpL 3316 proteins (data not shown) suggesting that binding does not take place at site 1 or site 2 of these mutants, respectively. However, a decrease in fluorescence intensity at 335 nm or above does occur when -chain binds to Y64W/A66W PpL 3316 , and an excitation wavelength of 280 nm is employed. This is almost certainly due to decreased FRET from Tyr 53 to Trp 64 when -chain occupies site 1 (see above).
The largest change in fluorescence intensity occurs when Y64W/Y53F PpL 3316 forms a complex with -chain (ex ϭ 280 nm or 295 nm). The Y53F mutation (site 1) has a clear effect on the fluorescence properties of Y64W in site 2. This could be due to a direct spectral perturbation (although the expected effect would be a decrease in fluorescence intensity from Y64W when excited at 280 nm, see above) or more probably a consequence of the decrease in affinity at site 1 caused by this mutation (9) .
Under the conditions of the above experiments there is only sufficient -chain to form a 1:1 mol:mol complex with PpL 3316 . As a result, sites 1 and 2 are both competing for the available -chain, with the amount bound to each site being dependent upon the relative affinities of the sites. Therefore, any mutation (e.g. Y53F) that causes a decrease in the amount of -chain bound at site 1 will lead to a concomitant increase in -chain available to bind to site 2 and thus have an effect on the magnitude of the signal change from either Trp 34 or Trp 64 . Pre-equilibrium Binding Studies-Stopped-flow fluorescence techniques were used to study the binding reactions between mutant PpL 3316 proteins and -chain. They illustrated that the observed fluorescence changes that occur for the Y64W/Y53F, Y64W, I34W/Y53F, and I34W mutants seen above are in fact the net results of more complex changes (Fig. 2) .
The single mutation Y64W produces a domain that shows large and complex changes in fluorescence when mixed with -chains. When excited at 280 nm a rapid increase in fluorescence intensity is followed by a slow and larger decrease. The binding of I34W to -chain under these conditions also appears to be a two-step process, both steps being accompanied by a decrease in fluorescence intensity. Biphasic kinetics such as these have been observed previously and occur when the mutant F39W PpL 3316 is mixed with -chain (9). The unidirectional, biphasic fluorescence intensity changes observed in those studies are consistent with a system in which the rapid fluorescence change corresponds to the formation of an encounter complex that subsequently undergoes a slower local rearrangement from a low affinity complex to a high affinity equilibrium complex. However, this model cannot explain the reaction progress curves that show more complex bidirectional fluorescence changes. In view of the recent crystallographic results that detail the existence of a second, albeit much weaker, binding site for -chain on PpL 3316 , we can now reconcile these data with a two-site binding model. This model not only explains the complex fluorescence changes described above but also allows the K d for the two binding sites to be determined.
In this model -chains bind independently to sites 1 ( 1 ) and 2 ( 2 ) on 1 PpL 2 . The overall K d for each site will depend upon the ratios of their dissociation (k Ϫ1 and k Ϫ2 ) and association rate constants (k 1 and k 2 ), respectively. Thus if the two sites have different K d values for their respective complexes with -chains and the rates of association of -chain to the two sites are similar, then the rates of dissociation from these sites must be different. Such a phenomenon (17) will explain the biphasic fluorescence changes described above. For example, consider the situation when PpL 3316 is present in excess and the rates of association to each site are similar. Under these conditions the -chain will initially bind to both sites 1 and 2. However, if site 2 has a higher dissociation rate than site 1 the occupancy of site 2 decreases and the -chain is redistributed in favor of site 1. Thus a reporter group in site 2, e.g. Trp 64 , may show an initial fluorescence increase, as it becomes less solvent exposed due to the binding of -chain, followed by a decrease in fluorescence as the -chain is redistributed in favor of site 1. Similarly, the site 1 reporter group F39W shows a biphasic change on complex formation. In this case an initial rapid increase in fluorescence intensity, due to binding of free -chain to this site, followed by a slower increase, due to the further saturation of available site 1 a consequence of -chain being released from site 2. This is in accord with previous data (9) . An alternative reporter group in site 1, I34W, which lies on the opposite side of ␤ strand 2 and points away from the helix, interestingly shows a biphasic decrease in fluorescence on formation of a complex with -chain.
If the binding of -chain to each site is independent of the presence of -chain at the other site, then rates k 1 , k Ϫ1 , k 2 , and k Ϫ2 will be the same as rates k 4 , k Ϫ4 , k 3 , and k Ϫ3 , respectively . However, in the presence of excess PpL 3316 the complex involving one PpL 3316 domain and two -chains (⅐ 1 PpL 2 ⅐, shown boxed in Scheme 1) will not be present in significant amounts.
This model is supported by the dramatic effects of the additional mutation Y53F on the fluorescence properties and the reaction progress curves observed on complex formation. It virtually eliminates the second, slow decrease in fluorescence intensity shown by Trp 64 (Fig. 2) and is almost certainly attributable to the decreased affinity of site 1, a result of the Y53F replacement (9) . Thus if the affinity of site 1 is decreased to, or below that, of site 2, then under the conditions used, more -chain will remain bound to site 2, and the fluorescence intensity at equilibrium from Trp 64 will be higher. This conclusion is supported by experiments using the mutant I34W/Y53F. This protein gives a reaction progress curve that appears to have a single-phase fluorescence change with a decreased amplitude compared with that observed for the binding of the single mutant I34W to -chain. These observations are consistent with the idea that the Y53F mutation reduces the affinity of site 1 close to that of site 2.
Finally, I34W/Y53F/L57H PpL 3316 containing the binding site mutations Y53F/L57H with the site 1 reporter Trp 34 shows no fluorescence change when mixed with -chain. This is because binding at site 1 has been substantially reduced/eliminated, and any significant remaining -chain binding is due to site 2. This is supported by the results gained from experiments using the same site mutations but with the Y64W reporter (Y64W/Y53F/L57H PpL 3316 ). This domain binds -chain resulting in the largest increase in fluorescence intensity (see Fig. 2 ). Assuming that the spectral response of the Trp 64 reporter group, excited by light at 295 nm, is not affected directly by the substitutions on the opposite side of the domain, these data suggest that the fluorescence intensity of Y64W PpL 3316 at equilibrium reflects the occupancy of site 2 only. Thus the large fluorescence change given by Y64W/Y53F/L57H and the absence of any fluorescence change for the same reaction with I34W/Y53F/L57H support the proposal that all of the bound -chain is located at site 2. If the binding model described in the above scheme is correct then one would expect to see different reaction progress curves when the experiment is repeated with increasing concentrations of -chain. Eventually there will be sufficient -chain to occupy both binding sites to give the species ⅐ 1 PpL 2 ⅐, and thus the reaction progress curves will become monophasic. Such an experiment is described in Fig. 3 , which displays three reaction curves in which 1.5 M Y64W PpL 3316 is mixed with 1.8, 9.9, and 28.8 M -chain. There is a clear reduction in the amplitude of the slow decrease in fluorescence as the concentration of -chain is increased. This reflects the increased occupancy of site 2 at equilibrium due to the higher concentration of -chain. Fig. 4 ) have shown that wt, L57H, Y53F, and Y53F/L57H domains have identical far UV CD spectra suggesting that the substitutions have not disturbed the secondary structures of the proteins. The presence of Trp residues in position 34 or 64 leads to an increase in ellipticity between 205 and 210 nm that is almost certainly due to spectral contributions from the aromatic side chains rather than disruption of the secondary folding of the protein. Furthermore, the structure of Y64W obtained by x-ray studies shows no significant backbone differences to that of the wt PpL 3316 (18). Further mutations, e.g. Y53F, L57H, or Y53F/ SCHEME 1. Two-site binding model. L57H made to the I34W or Y64W domains, caused no further spectral changes again indicating that they do not disrupt the folding of PpL 3316 .
Do the Mutations Alter the Structure of the PpL Domain?-Circular dichroism studies (see

Does the Binding Reaction Involve a Change in Structure of the Complex?-
The determination of the x-ray crystallographic structures of the complexes between wt PpL 3316 and a human Fab (10) and Y64W PpL 3316 and a mouse Fab (18) have shown that the secondary structure of the free PpL 3316 is the same as that of PpL 3316 in the complex. Furthermore, the far-UV CD spectrum of wt PpL 3316 is the same in the absence or presence of an equimolar concentration of -chain (see inset to Fig. 4) suggesting that there is no change in secondary structure on complex formation.
Determination of K d for Complexes at Sites 1 and 2-By determining the rates k 1 , k Ϫ1, k 2 , and k Ϫ2 for -chain binding to sites 1 and 2 of PpL 3316 , respectively, the K d of the complex at each site can be determined. In experiments using domains with both sites functioning then the overall observed rate of association, k a , will be a combination of the association rates for each site (k 1 ϩ k 2 , see Fig. 5 ). Thus to determine the association rate to each site individually it was necessary to eliminate the alternative site in each case. This was achieved by the mutations Y53F/L57H and A66W on the I34W or Y64W templates. These remove binding capacity at sites 1 and 2, respectively. k a can be calculated from the slope of a plot of the observed rate, k app , against the concentration of the variable ligand (PpL 3316 ). Such data using various PpL 3316 mutants are given in Table III . In the absence of -chain binding at site 1 the reaction of -chain with site 2 of the Y64W/Y53F/L57H PpL 3316 mutant is a simple bimolecular binding process and the observed rate of reaction k app ϭ k 2 [Y64W/Y53F/L57H PpL 3316 ] ϩ k Ϫ2 (see Fig. 5 ). The variation of k app with varying concentrations of Y64W/Y53F/L57H PpL 3316 is shown in the inset to Fig. 5 , and the value of k 2 is 0.15 Ϯ 0.02 M Ϫ1 s Ϫ1 (Table III) . Similarly experiments show that k 1 for binding at site 1 (using the mutant I34W/A66W) is 0.25 Ϯ 0.01 M Ϫ1 s Ϫ1 at 25°C. The sum of these two association rate constants (0.40 M Ϫ1 s
Ϫ1
) is very close to that determined for domains in which binding occurs to both sites simultaneously, as described above, e.g.
). To corroborate these calculations we used domains with the Trp 34 reporter and determined k 1 and k Ϫ1 for the reaction by rapidly mixing a constant amount of the PpL 3316 domain with various excess concentrations of -chain, the latter always in large excess so that pseudo-first order conditions can be achieved. The observed rate of reaction k app will depend upon the concentration of -chain, and a plot of k app against -chain concentration yielded a line of slope k 1 , in this case 0.23 Ϯ 0.04 M Ϫ1 s Ϫ1 (data not shown), which is in close agreement with the values determined by other methods (see Table III ).
Determination of the Rates of Dissociation of the Complexes-
Although estimates of the dissociation rates k Ϫ1 or k Ϫ2 can be obtained from the intercept on the ordinate of the plot shown in the inset to Fig. 5 , these are prone to large errors when their values are so low (19) . Therefore rates of dissociation of the complexes between PpL 3316 domains and -chain were measured as described under "Experimental Procedures," and the data are summarized in Fig. 6, a-c, I34W/Y53F PpL 3316 ⅐-chain complex (containing the additional Y53F mutation) is ϳ65-fold greater (0.84 Ϯ 0.01 s Ϫ1 ), thus giving rise to a large increase in the value of K d (see Table III) as noted previously (9) .
The fluorescence changes that accompany the dissociation of the Y64W PpL 3316 ⅐-chain complex can be resolved into two distinct steps when an excitation wavelength of 280 nm is used. A fluorescence decrease occurs with a rate of 0.56 Ϯ 0.02 s Ϫ1 , followed by a much slower fluorescence increase with a rate of 0.008 Ϯ 0.001 s Ϫ1 , the latter of which is comparable with the rate of dissociation noted for the I34W PpL 3316 ⅐-chain complex. The dissociation of the Y64W/Y53F PpL 3316 ⅐-chain and Y64W/Y53F/L57H PpL 3316 ⅐-chain complexes are both accompanied by single-phase fluorescence decreases with rates of 0.41 Ϯ 0.03 s Ϫ1 and 0.50 Ϯ 0.02 s Ϫ1 , respectively. Thus by introducing the mutations Y53F or Y53F/L57H into the Y64W PpL 3316 template the initial phase of dissociation of the PpL 3316 ⅐-chain complex is relatively unaffected but the slower dissociation step is no longer observed suggesting this is due to dissociation from site 1. The K d values for the complexes formed by the above PpL 3316 domains and -chain are given in Table III .
When the dissociation experiment with the Y64W PpL 3316 ⅐-chain complex was repeated using an excitation wavelength of 295 nm, only the initial fluorescence decrease was apparent (Fig. 6c) . We can conclude from this that the initial fluorescence decrease is due to changes in the environment of Trp 64 as the -chain dissociates from site 2. The slower fluorescence change noted when the excitation wavelength is 280 nm arises from increased FRET from Tyr 53 as the complex at site 1 dissociates (removing quenching from Tyr 53 ). Therefore it is possible to simultaneously observe dissociation at sites 1 and 2. Using the values of the rates of association (k 2 ) and dissociation (k Ϫ2 ) of the Y64W/Y53F/ L57H PpL 3316 ⅐-chain complex from the above experiments the K d at site 2 is 3.4 Ϯ 0.70 M (Table III) .
Sequential Mixing Stopped-flow Fluorimetry-In the original single site binding model shown below (9) , it was proposed that two structurally different forms of the PpL 3316 ⅐-chain complex exist.
In this scheme k a and k diss represent the rates of association and dissociation, respectively, of the encounter complex PpL⅐, and k f and k r represent the forward and reverse rates of the structural rearrangement, respectively.
In the proposed model (9) the transition from PpL⅐ to [PpL⅐]* was suggested to increase the affinity by ϳ30-fold. Thus under equilibrium conditions, the majority of the PpL and -chain would be present in the form of the high affinity complex. Also dissociation of the encounter complex occurs rapidly, while dissociation of the equilibrium complex is rate limited by k r (9) . Therefore upon dissociation of the complex at equilibrium most of the observed fluorescence change would occur with the rate kr. However, if dissociation of the PpL⅐-chain complex is invoked shortly after the mixing of PpL and -chain, before the encounter complex has undergone the structural rearrangement, the observed rate would be k diss , that of the dissociation of the encounter complex. When both encounter and equilibrium complexes are present, the observed dissociation profile would be expected to be biphasic, the amplitude of each phase being dependent on the relative abundance of each complex.
However, sequential-mixing stopped-flow studies on the dissociation of the I34W PpL 3316 ⅐-chain complex reveal a single-phase fluorescence increase upon dissociation. Regardless of the incubation time prior to initiation of dissociation, a rate constant of ϳ0.01 s Ϫ1 was observed. Therefore, the formation of the I34W PpL 3316 ⅐-chain complex does not appear to occur by a two step process involving a structural rearrangement.
Isothermal Titration Calorimetry-Isothermal titration calorimetry was used to verify the K d values obtained for -chain binding to sites 1 and 2 of PpL 3316 determined using the fluorimetric methods above. To attempt to resolve binding to sites 1 and 2, -chain was titrated into wt PpL 3316 . As a result of the very high concentration of -chain required when used as the titrant the data required significant correction for the contribution to the enthalpy profile due to -chain dilution. The K d values for sites 1 and 2 were estimated to be 21.1 Ϯ 10.21 nM and 7.5 Ϯ 3.1 M. respectively (see Table IV ). The enthalpic contributions to binding at sites 1 and site 2 were Ϫ54.3 Ϯ 0.7 kJ/mol and Ϫ28.1 Ϯ 6.2 kJ/mol, respectively, and the entropic changes were Ϫ41.4 and 0.7 J/mol/degree, respectively. However, to accurately determine these values for each site, mutants in which either site 1 or site 2 had been eliminated were used. Titration of Y64W/Y53F/L57H PpL 3316 into -chain allows the binding at site 2 to be measured. Clear enthalpy profiles are obtained (see Fig. 7 Binding data from these titrations were analyzed using the manufacturer's software. by such techniques as enzyme-linked immunosorbent assay will reflect the presence of both sites. Thus we have resolved the issue by the production of mutants that have binding at one site or the other eliminated under these experimental conditions. Fig. 2 shows that the final level of fluorescence ( ex ϭ 295 nm) from the complex formed by mixing a 1:1 mol:mol ratio of Y64W PpL 3316 and -chain is indicative of the relative occupancy of site 2. Thus if all of the bound -chain is at site 1, then there is little fluorescence increase at equilibrium from the Trp 64 and vice versa. A domain with two sites of equal affinity would show equilibrium fluorescence intensity half way between the two extremes described above. We estimate that for the Y64W PpL 3316 ⅐-chain complex, greater than 95% of the -chain is bound to site 1, and this is reflected by an ϳ2% net increase in the fluorescence intensity at equilibrium. The residual fluorescence intensity at equilibrium given by Y64W/ Y53F is more than half of the fluorescence intensity difference given by Y64W and Y64W/Y53F/L57H (which shows no binding at site 1). This therefore suggests that the Y64W/Y53F has an affinity for -chain at site 1 that is lower than its affinity at site 2. This is supported by the K d values for the various complexes shown in Table III in which the K d for the I34W/Y53F PpL 3316 ⅐-chain complex (site 1) is 4.4 M and that for the Y64W/Y53F/L57H PpL 3316 ⅐-chain (site 2) is 3.4 M. In the Y64W/Y53F/L57H complex 100% of the bound -chain is at site 2, and hence this has a K d equal to 3.4 Ϯ 0.7 M (see Table III ).
The new model that explains the biphasic fluorescence changes that occur on complex formation is consistent with previous data (9) , although the previously proposed structural rearrangement (9) , suggested by a slow change in fluorescence with a first order rate constant that is independent of the concentration of ligand, is now known to be the dissociation of -chain from the weaker site. Possible alternative models involving oligomeric forms of the protein can be eliminated as sedimentation studies carried out on PpL 3316 have confirmed that the domain exists as a monomer in solution. 2 The Y53F mutation dramatically increases the rate of dissociation of -chain from site 1 due to the loss of the hydrogen bond formed between the hydroxyl group and the peptide carbonyl group of Thr 20 . This leads to a decrease in affinity of at least 90-fold to yield a K d of 4.42 M, higher than in a previous report (9) . However, it is now clear from the studies described in this paper that the affinity (3.2 M) measured in (9) was for -chain binding that was occurring at the then unreported weaker binding at site 2.
To date, the binding of wt PpL 3316 to two different -chains has been studied. These are a human 1-chain (1 T ) described here and the other a human Fab (2A2 (10) ). Additionally the binding of mutated PpL 3316 domains to a murine 9 (Fab 19D9D6) has been studied (12) . All of these confirm the presence of two binding sites per domain although the elimination of site 2 for the murine 9 (Fab 19D9D6) has been demonstrated for the mutant D55A (12) . Binding at the second site is not easily detected due to the presence of the much higher affinity site 1. However, this problem is eliminated when site 1 is either weakened or abrogated and thus by use of suitable mutants we have in these studies been able to measure the affinity of site 2 for -light chains.
Because the binding interactions at sites 1 and 2 involve backbone and different side chain contacts between PpL 3316 and -chain, it is probable that the relative affinities of each site for -chains may depend upon the subclass or origin of the -chain. This may well offer an advantage to the bacterium, allowing it to maximize potential binding capacity.
